A NEW METHOD OF SCORING CORONARY ANGIOGRAMS TO REFLECT EXTENT OF CORONARY ATHEROSCLEROSIS AND IMPROVE CORRELATION WITH MAJOR RISK-FACTORS

被引:220
作者
SULLIVAN, DR
MARWICK, TH
FREEDMAN, SB
机构
[1] ROYAL PRINCE ALFRED HOSP,INST CARDIOL,DEPT CLIN BIOCHEM,MISSENDEN RD,CAMPERDOWN,NSW 2050,AUSTRALIA
[2] ROYAL PRINCE ALFRED HOSP,DEPT CLIN BIOCHEM,CAMPERDOWN,NSW 2050,AUSTRALIA
[3] UNIV SYDNEY,SYDNEY,NSW 2006,AUSTRALIA
关键词
D O I
10.1016/S0002-8703(05)80173-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We developed a new angiographic score of the extent of coronary disease (extent score), which we compared with conventional stenosis and vessel scores that emphasize the severity of stenosis. Scores were determined in 132 patients (29 women, 103 men with a mean age of 55±10 years) who underwent elective coronary angiography. Risk factors were more closely related to the extent score than to either the stenosis or vessel scores (Total R2=0.35 versus 0.28 (p<0.001) and 0.25 (p<0.001), respectively). The extent score was more closely related to age (r=0.30, p<0.05), than was either stenosis (r=0.21 ns) or vessel score (r=0.26, p<0.05). Apolipoprotein B was the strongest predictor of both extent and stenosis scores but was more closely related to the extent score (r=0.36, p<0.05), even after correction for age and gender. This new angiographic score that asesses the extent of coronary disease is simple to perform and correlates better with age and lipoprotein risk factors than conventional scores do. © 1990.
引用
收藏
页码:1262 / 1267
页数:6
相关论文
共 37 条
[1]  
[Anonymous], CORONARY ARTERIOGRAP
[2]   DIET, LIPOPROTEINS, AND THE PROGRESSION OF CORONARY ATHEROSCLEROSIS - THE LEIDEN INTERVENTION TRIAL [J].
ARNTZENIUS, AC ;
KROMHOUT, D ;
BARTH, JD ;
REIBER, JHC ;
BRUSCHKE, AVG ;
BUIS, B ;
VANGENT, CM ;
KEMPENVOOGD, N ;
STRIKWERDA, S ;
VANDERVELDE, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) :805-811
[3]  
Austen W G, 1975, Circulation, V51, P5
[4]  
AVOGARO P, 1979, LANCET, V1, P901
[5]   RELATIONSHIP BETWEEN APOLIPOPROTEINS AND CHEMICAL-COMPONENTS OF LIPOPROTEINS IN SURVIVORS OF MYOCARDIAL-INFARCTION [J].
AVOGARO, P ;
BITTOLOBON, G ;
CAZZOLATO, G ;
RORAI, E .
ATHEROSCLEROSIS, 1980, 37 (01) :69-76
[6]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
[7]   EFFECTS OF THERAPY WITH CHOLESTYRAMINE ON PROGRESSION OF CORONARY ARTERIOSCLEROSIS - RESULTS OF THE NHLBI TYPE-II CORONARY INTERVENTION STUDY [J].
BRENSIKE, JF ;
LEVY, RI ;
KELSEY, SF ;
PASSAMANI, ER ;
RICHARDSON, JM ;
LOH, IK ;
STONE, NJ ;
ALDRICH, RF ;
BATTAGLINI, JW ;
MORIARTY, DJ ;
FISHER, MR ;
FRIEDMAN, L ;
FRIEDEWALD, W ;
DETRE, KM ;
EPSTEIN, SE .
CIRCULATION, 1984, 69 (02) :313-324
[8]   EFFECT OF CLOFIBRATE ON PROGRESSION OF CORONARY-DISEASE - PROSPECTIVE ANGIOGRAPHIC STUDY IN MAN [J].
COHN, K ;
SAKAI, FJ ;
LANGSTON, MF .
AMERICAN HEART JOURNAL, 1975, 89 (05) :591-598
[9]   DISCRIMINATIVE VALUE OF LIPIDS AND APOPROTEINS IN CORONARY HEART-DISEASE [J].
DEBACKER, G ;
ROSSENEU, M ;
DESLYPERE, JP .
ATHEROSCLEROSIS, 1982, 42 (2-3) :197-203
[10]  
DEMACKER PN, 1984, CLIN CHEM, V30, P1797